## Histological Distinction: Osteosarcoma vs. Reactive/Inflammatory Lesions ### Core Diagnostic Principle **Key Point:** The **direct production of osteoid/bone by malignant tumor cells** (not by reactive osteoblasts) is the pathognomonic histological hallmark of osteosarcoma. This is the sine qua non for diagnosis. ### Histological Comparison Table | Feature | Osteosarcoma | Osteomyelitis + Reactive Bone | | --- | --- | --- | | **Osteoid/bone producer** | Malignant tumor cells (DIAGNOSTIC) | Reactive osteoblasts (non-neoplastic) | | **Pleomorphism** | Marked, atypical | Minimal, uniform | | **Mitotic rate** | High, including abnormal forms | Low, normal forms | | **Cellularity** | Hypercellular, crowded | Moderate, organized | | **Inflammatory infiltrate** | Variable, may be present | Prominent, polymorphs + macrophages | | **Necrosis** | Tumor necrosis common | Suppurative necrosis (pus) | ### Why Tumor Osteoid is the Best Discriminator **High-Yield:** Osteomyelitis with reactive bone formation shows **reactive osteoblasts** (benign, uniform cells) laying down bone in response to inflammation. Osteosarcoma shows **malignant spindle cells themselves producing osteoid**—the tumor cells are the source, not a reactive response. **Clinical Pearl:** In osteomyelitis, the bone-forming cells are normal osteoblasts responding to infection; in osteosarcoma, the neoplastic cells have acquired the ability to produce osteoid, which is a marker of malignant transformation. ### Diagnostic Criteria (WHO) Osteosarcoma is defined as a malignant tumor of bone in which the neoplastic cells produce **osteoid or bone**. This is a defining criterion, not just a supporting feature. **Mnemonic:** **TUMOR OSTEOID** = **T**umor cells **U**ndergo **M**alignant **O**steoid **R**eaction = **O**steosarcoma **S**pecific **T**eroid **E**vidence **O**f **I**nvasive **D**isease. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.